Artiva Biotherapeutics, Inc. (ARTV) Operating cash flow 2023–2025
Artiva Biotherapeutics, Inc. (ARTV) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$76.8MFY2025 · since FY2023: -$47.4M → -$76.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$76.8M | -39.5% |
| FY2024 | -$55.0M | -16.0% |
| FY2023 | -$47.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ARTV financial trends
ARTV RevenueARTV Net incomeARTV Net marginARTV Gross profitARTV Gross marginARTV Operating incomeARTV Operating marginARTV Free cash flowARTV Capital expendituresARTV Return on equityARTV Stock buybacksARTV Dividends paidARTV Total assetsARTV Total liabilitiesARTV Shareholders’ equityARTV overview →